StockData
MSA Safety Inc logo

MSA Safety Inc (MSA) stock analysis

MSANYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as MNESP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 17/3019% below fair value
$176.24+1.00 (+0.57%)

Close on Nov 11, 2026Market cap $6.80BP/E 21.9Yield 1.19%

StockData Score

Prices as of Nov 11, 2026How the score works

Value4Growth2Performance3Health4Dividend4

Solid17 of 30 checks passed

MSA Safety passes 17 of the 30 checks behind our score; 6 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
4/6
Growth
2/6
Past performance
3/6
Financial health
4/6
Dividend
4/6

What stands out

  • Trading below fair value

    The share price of $176.24 is below our fair value estimate of $217.09.

  • Earnings grew over 5 years

    Net income grew 17.6% a year on average over the last five fiscal years.

  • EPS growing 10%+ a year

    Diluted EPS grew 15.8% a year over the last three fiscal years.

  • Interest well covered

    Operating income covers interest expense 12.7 times.

What to watch

  • Margin of safety under 20%

    The price is 18.8% below fair value, less than the 20% cushion we look for.

  • Revenue growing under 10% a year

    Revenue grew 7.1% a year over the last three fiscal years, short of the 10% we look for.

  • Earnings growth not accelerating

    Net income grew 13.4% over the last twelve months, against a 5-year average of 17.6% a year.

  • P/S above the industry

    MSA Safety's price-to-sales of 3.49 is above the Surgical, Medical, and Dental Instruments and Supplies median of 2.82 (book value is negative, so we use sales).

Valuation4/6
  • P/E below its 5-year median

    MSA Safety's P/E of 21.9 is below its own 5-year median of 27.3.

  • P/E below the industry

    MSA Safety's P/E of 21.9 is below the Surgical, Medical, and Dental Instruments and Supplies median of 27.7.

  • EV/EBITDA below its 5-year median

    MSA Safety's EV/EBITDA of 14.7 is below its 5-year median of 18.6.

  • P/S above the industry

    MSA Safety's price-to-sales of 3.49 is above the Surgical, Medical, and Dental Instruments and Supplies median of 2.82 (book value is negative, so we use sales).

  • Trading below fair value

    The share price of $176.24 is below our fair value estimate of $217.09.

  • Margin of safety under 20%

    The price is 18.8% below fair value, less than the 20% cushion we look for.

Growth2/6
  • Revenue growing under 10% a year

    Revenue grew 7.1% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing 10%+ a year

    Diluted EPS grew 15.8% a year over the last three fiscal years.

  • Earnings growth not accelerating

    Net income grew 13.4% over the last twelve months, against a 5-year average of 17.6% a year.

  • Growing slower than the industry

    Revenue grew 6.5% over the last twelve months; the Surgical, Medical, and Dental Instruments and Supplies median is 11.0%.

  • Company guidance

    No outlook found in earnings releases from the last twelve months.

  • Gross margin improving

    Gross margin was 47.6% over the last twelve months, against 46.8% a year earlier.

Past performance3/6
  • Return on equity

    Needs positive equity and five years of results.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity against the industry

    Needs positive equity.

  • Earnings grew over 5 years

    Net income grew 17.6% a year on average over the last five fiscal years.

  • Net margin above its 5-year average

    Net margin was 16.1% over the last twelve months, against a 5-year average of 9.4%.

  • Net margin above the industry

    MSA Safety's net margin of 16.1% is above the Surgical, Medical, and Dental Instruments and Supplies median of -14.1%.

Financial health4/6
  • Debt level

    Needs debt and equity figures.

  • Debt trend

    Needs a balance sheet from five years ago with positive equity.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 67.7% of total debt.

  • Interest well covered

    Operating income covers interest expense 12.7 times.

  • Short-term assets cover short-term debts

    Current assets are 3.24 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 5.86; above 3 is the safe zone and below 1.8 the distress zone.

Dividend4/6
  • Pays a dividend

    MSA Safety paid dividends worth 1.2% of the share price over the last twelve months.

  • Yield below Treasuries

    The 1.2% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; MSA Safety yields 1.2%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 7 fiscal years.

  • Covered by earnings

    Dividends take 26.4% of net income.

  • Covered by free cash flow

    Dividends take 23.4% of free cash flow.

Scores of similar companies

Our estimate per share

$217.09

The share price is 19% below this estimate.

20%+ below
Near fair value
20%+ above
$176.24Price$217.09Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E27.5×27.3×27.7×$220.9753%
EV/EBITDA17.6×18.6×16.7×$212.6447%
Earnings powerleft out, too far from the others9.4% cost of equity––$53.91–
Fair value$217.09100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 27.3
  • Surgical, Medical, and Dental Instruments and Supplies median 27.7

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$49.82M
Value traded per 1% price move
$44.81M

Downside

Low risk

Typical loss in a bad month
14.1%
Volatility (annualized)
26%
Sharpe ratio, 1 year
0.21
Beta to the S&P 500 (5Y)
0.91

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

46.5%+2.3 pts over 5 years

Operating margin

19.8%+7.1 pts over 5 years

Net margin

14.9%+5.7 pts over 5 years

See a number that looks wrong?